These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926 [No Abstract] [Full Text] [Related]
3. Viral Coagulopathy in Patients With COVID-19: Treatment and Care. Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449 [TBL] [Abstract][Full Text] [Related]
10. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial. Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19. Hashemi A; Madhavan MV; Bikdeli B Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478 [No Abstract] [Full Text] [Related]
13. Long lasting hypercoagulability after subclinical COVID-19. Ferroli P; Villa C; Ciuffi A; Gubertini G; Broggi M J Thromb Thrombolysis; 2020 Nov; 50(4):822-824. PubMed ID: 32757154 [No Abstract] [Full Text] [Related]
14. COVID-19 and Hypercoagulable State: A New Therapeutic Perspective. Nascimento JHP; Gomes BFO; Carmo Júnior PRD; Petriz JLF; Rizk SI; Costa IBSDS; Lacerda MVG; Bacal F; Hajjar LA; Oliveira GMM Arq Bras Cardiol; 2020 Jun; 114(5):829-833. PubMed ID: 32491074 [No Abstract] [Full Text] [Related]
15. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Miesbach W; Makris M Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459 [TBL] [Abstract][Full Text] [Related]
16. Coagulopathy of Coronavirus Disease 2019. Iba T; Levy JH; Levi M; Connors JM; Thachil J Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443 [TBL] [Abstract][Full Text] [Related]
17. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Amgalan A; Othman M Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506 [TBL] [Abstract][Full Text] [Related]
18. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Saini KS; Lanza C; Romano M; de Azambuja E; Cortes J; de Las Heras B; de Castro J; Lamba Saini M; Loibl S; Curigliano G; Twelves C; Leone M; Patnaik MM Br J Cancer; 2020 Sep; 123(5):694-697. PubMed ID: 32572174 [TBL] [Abstract][Full Text] [Related]